Artificial Vital Organs And Medical Bionics Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What Is the Forecasted Market Size and Growth Rate for the Artificial Vital Organs And Medical Bionics Market?
In the last few years, the market for artificial vital organs and medical bionics has seen considerable growth. Its value is expected to increase from $43.1 billion in 2024 to $46.95 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.9%. The growth during the historic period could be due to factors such as increased public awareness and acceptance, advancements in surgical procedures, a lack of donor organs, a surge in chronic diseases, and efficient regulatory processes and approvals.

There is a promising projection for the artificial vital organs and medical bionics market in the coming years with its size expected to climb to $65.24 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.6%. This upward trend over the forecast period can be linked to numerous factors including the rising rates of organ failure, an increase in the elderly population, a surge in healthcare spending, the preference for less invasive surgical procedures, and the expansion of regenerative medicine and tissue engineering. The growth in this timeframe is further propelled by advancements such as biotechnological innovations, an increased financial input to healthcare from both public and private sectors, the development of biomaterials and materials that are biocompatible, enhanced R&D efforts, and improved patient results.

What Factors Are Propelling the Expansion of the Artificial Vital Organs And Medical Bionics Market?
The increase in organ failure instances is projected to fuel the expansion of the artificial vital organs and medical bionics market in the future. Organ failure, a severe condition in which one or multiple organs cease to function correctly, can lead to serious health issues and potential life-threatening situations. This surge in organ failures is fueled by increasing cases of chronic ailments like diabetes, hypertension, and heart disease, as well as congenital conditions and genetic vulnerabilities that might result in organ failure. Artificial vital organs and medical bionics are critical in addressing organ failures by offering life-preserving support and reinstating vital functions in patients with deteriorated organs. For example, in January 2023, the United Network for Organ Sharing, a scientific and educational non-profit organization based in the US, reported that there were 42,887 organ transplants conducted in the United States in 2022. This was a 3.7% increase from the previous year, setting a new annual record. Consequently, the escalating prevalence of organ failures is anticipated to stimulate the growth of the artificial vital organs and medical bionics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20488&type=smp

Which Businesses Are at the Forefront of Artificial Vital Organs And Medical Bionics Market Development?
Major companies operating in the artificial vital organs and medical bionics market are Abiomed Inc., Abbott Laboratories, Medtronic Plc, Fresenius Medical Care AG, Asahi Kasei Corporation, Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT, Iwalk Inc., BiVACOR Inc., Nano Retina Inc., Second Sight Medical Products Inc., St. Jude Medical Inc.

Which Businesses Are at the Forefront of Market Development?
Major businesses in the artificial vital organs and medical bionics industry are focusing on creating superior technology products like the bionic pancreas, aiming to improve patient results and fulfill the rising need for advanced medical assistance. A bionic pancreas is a sophisticated piece of medical equipment that automates the blood sugar control process in diabetic patients, thereby replicating the function of a healthy pancreas. To illustrate, in December 2023, Beta Bionics Inc., a medical technology firm based in the United States, unveiled the iLet Bionic Pancreas. This self-regulating insulin delivery system simplifies diabetes care by automatically tailoring insulin delivery to the user's weight, thus preventing the need for healthcare professionals to manage complicated parameters like correction factors, insulin-to-carb ratios, or pre-set basal rates. This ultimately decreases the stress for both patients and doctors.

How Is the Artificial Vital Organs And Medical Bionics Market Segmented?
The artificial vital organs and medical bionics market covered in this report is segmented -

1) By Type: Artificial Vital Organs, Medical Bionics
2) By Technology: Mechanical, Electronic
3) By Application: Hospitals, Clinics, Other Applications

Subsegments:
1) By Artificial Vital Organs: Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Lungs, Artificial Pancreas
2) By Medical Bionics: Bionic Limbs, Bionic Eyes, Bionic Ears, Neural Implants, Bionic Organs

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/artificial-vital-organs-and-medical-bionics-global-market-report

Where Is the Artificial Vital Organs And Medical Bionics Market Growth Most Prominent?
North America was the largest region in the artificial vital organs and medical bionics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial vital organs and medical bionics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Artificial Vital Organs And Medical Bionics Global Market Report?

- Market Size Analysis: Analyze the artificial vital organs and medical bionics Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the artificial vital organs and medical bionics market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall artificial vital organs and medical bionics market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the artificial vital organs and medical bionics market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20488

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.